Bio-Rad Laboratories Inc (BUWA.MU)
Munich - Munich Delayed price. Currency in EUR
Add to watchlist
As of 08:04AM CEST. Market open.
| Previous close | 262.20 |
| Open | 255.40 |
| Bid | 253.10 x N/A |
| Ask | 255.40 x N/A |
| Day's range | 255.40 - 255.40 |
| 52-week range | 250.60 - 387.20 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Is It Wise to Hold Bio-Rad (BIO) Stock in Your Portfolio Now?
Bio-Rad's (BIO) robust digital PCR business and Clinical Diagnostics segment raise optimism. However, macro issues raise concerns.
- Insider Monkey
Is Bio-Rad Laboratories (BIO) a Lucrative Investment?
Ariel Investments, an investment management company, released its “Ariel Appreciation Fund” first-quarter 2024 investor letter. A copy of the letter can be downloaded here. The Ariel Appreciation fund increased +4.06% in the quarter, trailing the +8.23% and +8.60% returns of the Russell Midcap Value and Russell Midcap indices. Except for real estate, all sectors in the […]
- Zacks
Phibro (PAHC) Down 3.3% Since Last Earnings Report: Can It Rebound?
Phibro (PAHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
© 2024 Yahoo. All rights reserved.